17-(CYCLOPROPYLMETHYL)-3,10-DIHYDROXY-13-OXO-17-AZATETRACYCLO(7.5.3.01, 10.02,7)HEPTADECA-2(7),3,5-TRIENE-4-CARBOXYLIC ACID, (1R,9R,10S)-
UNII VU7FVJ2YAZ
Substance Identification & Data
This profile provides standardized clinical and technical data for 17-(cyclopropylmethyl)-3,10-dihydroxy-13-oxo-17-azatetracyclo(7.5.3.01, 10.02,7)heptadeca-2(7),3,5-triene-4-carboxylic Acid, (1r,9r,10s)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) VU7FVJ2YAZ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H25NO5 RLOJVXDMYFXXJT-MAODMQOUSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 17-(cyclopropylmethyl)-3,10-dihydroxy-13-oxo-17-azatetracyclo(7.5.3.01, 10.02,7)heptadeca-2(7),3,5-triene-4-carboxylic Acid, (1r,9r,10s)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.